-
Hormone therapy, also called androgen deprivation therapy or androgen suppression therapy, reduces androgen levels to prevent these hormones from reaching prostate cancer cells.
-
If the prostate-specific antigen (PSA) level shows that the prostate cancer has not been cured after an initial attempt, further treatment may be an option.
-
Research Scholar Grant (RSG)
Grant No. Investigator/Mentor/Institution Title Grant Term Grant Awarded
RSG-13-021-01 Arnold, Connie L., PhD
LSU Health Sciences Center in Shreveport
Department of General Internal Medicine
Shreveport, LA
Health Literacy...
-
The US Food and Drug Administration (FDA) has approved Erleada (apalutamide) to treat men with non-metastatic castration-resistant prostate cancer.
-
The following sources were used in preparing our information about prostate cancer.
-
Treating Prostate Cancer
cancer.org | 1.800.227.2345
If you've been diagnosed with prostate cancer, your cancer care team will discuss your
treatment options with you. It's important to weigh the benefits of each treatment option
against the possible ...
-
In 2018, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
-
Skip to Content
Menu
Search
...
-
Nuestro equipo de periodismo profesional pone a su disposición diversos artículos relacionados al cáncer desde todos los ángulos.
-
Nuestro equipo de periodismo profesional pone a su disposición diversos artículos relacionados al cáncer desde todos los ángulos.